Schlenker provided guidance: "For the third quarter 2025, as compared to 1 year prior, we expect revenues before reimbursements to be up in the middle single digits and EBITDA to be 26.75% to 27.75% ...

Last week, you might have seen that Exponent, Inc. (NASDAQ:EXPO) released its quarterly result to the market. The early response was not positive, with shares down 5.4% to US$68.33 in the past week.

Exponent's Q4 2024 earnings and revenue exceeded forecasts. Stock price increased by 3.54% in after-hours trading. Full-year 2024 revenues grew by 4% to $558.5 million. The company reported a 28.4% ...

Exponent (EXPO) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.41 per share a year ago. These figures are ...

Schlenker provided guidance for the fourth quarter, stating, "We expect revenues before reimbursements to grow in the low to mid-single digits, EBITDA to be 26% to 27% of revenues before ...

Exponent (EXPO) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.41 per share a year ago. These figures are ...